C.R.S. Section 18-18-206
Schedule IV

  • repeal

(1)

A substance shall be added to schedule IV by the general assembly when:

(a)

The substance has a low potential for abuse relative to substances included in schedule III;

(b)

The substance has currently accepted medical use in treatment in the United States; and

(c)

The abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in schedule III.

(2)

Unless specifically excepted by Colorado or federal law or Colorado or federal regulation or more specifically included in another schedule, the following controlled substances are listed in schedule IV:

(a)

Any material, compound, mixture, isomers or salts or isomers, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows:

(I)

Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit;

(II)

Propoxyphene (dosage forms);

(III)

Butorphanol;

(b)

Any material, compound, mixture, or preparation containing any quantity of the following substances having a depressant effect on the central nervous system, including any salts, isomers, and salts of isomers of them that are theoretically possible within the specific chemical designation:

(I)

Alprazolam;

(II)

Barbital;

(III)

Bromazepam;

(IV)

Camazepam;

(V)

Chloral betaine;

(VI)

Chloral hydrate;

(VII)

Chlordiazepoxide;

(VIII)

Clobazam;

(IX)

Clonazepam;

(X)

Clorazepate;

(XI)

Clotiazepam;

(XII)

Cloxazolam;

(XIII)

Delorazepam;

(XIV)

Diazepam;

(XV)

Estazolam;

(XVI)

Ethchlorvynol;

(XVII)

Ethinamate;

(XVIII)

Ethyl loflazepate;

(XIX)

Fludiazepam;

(XX)

Flunitrazepam;

(XXI)

Flurazepam;

(XXII)

Halazepam;

(XXIII)

Haloxazolam;

(XXIV)

Ketazolam;

(XXV)

Loprazolam;

(XXVI)

Lorazepam;

(XXVII)

Lormetazepam;

(XXVIII)

Mebutamate;

(XXIX)

Medazepam;

(XXX)

Meprobamate;

(XXXI)

Methohexital;

(XXXII)

Methylphenobarbital (mephobarbital);

(XXXIII)

Midazolam;

(XXXIV)

Nimetazepam;

(XXXV)

Nitrazepam;

(XXXVI)

Nordiazepam;

(XXXVII)

Oxazepam;

(XXXVIII)

Oxazolam;

(XXXIX)

Paraldehyde;

(XL)

Petrichloral;

(XLI)

Phenobarbital;

(XLII)

Pinazepam;

(XLIII)

Prazepam;

(XLIV)

Quazepam;

(XLV)

Temazepam;

(XLVI)

Tetrazepam;

(XLVII)

Triazolam;

(XLVIII)

Zolpidem;

(c)

Intentionally left blank —Ed.

(I)

Any material, compound, mixture, or preparation containing any quantity of the following substance, including any salts, isomers of it that are theoretically possible: Fenfluramine.

(II)

This paragraph (c) is repealed upon removal of fenfluramine and its salts and isomers from schedule IV of the federal “Controlled Substances Act” (21 U.S.C. sec. 812; 21 CFR 1308.14).

(d)

Any material, compound, mixture, or preparation containing any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers, and salts of isomers:

(I)

Cathine;

(II)

Diethylpropion;

(III)

Fencamfamin;

(IV)

Fenpropore;

(V)

Mazindol;

(VI)

Pemoline (including organometallic complexes and chelates thereof);

(VII)

Phentermine;

(VIII)

Pipradrol;

(IX)

SPA ((-)-1-dimethylamino-1,2-diphenylethane);

(e)

Any material, compound, mixture, or preparation containing any quantity of the following substances, including their salts and isomers:

(I)

Modafinil;

(II)

Pentazocine;

(III)

Sibutramine;

(IV)

Stadol (butorphanol tartrate);

(f)

Zaleplon.

(3)

The board may exempt by rule any compound, mixture, or preparation containing any depressant substance listed in paragraph (b) of subsection (2) of this section from the application of all or any part of this article if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances having a depressant effect on the central nervous system.

Source: Section 18-18-206 — Schedule IV - repeal, https://leg.­colorado.­gov/sites/default/files/images/olls/crs2023-title-18.­pdf (accessed Oct. 20, 2023).

18‑18‑101
Short title
18‑18‑102
Definitions
18‑18‑103
Special definition - board
18‑18‑201
Authority to control
18‑18‑202
Nomenclature
18‑18‑203
Schedule I
18‑18‑204
Schedule II
18‑18‑205
Schedule III
18‑18‑206
Schedule IV - repeal
18‑18‑207
Schedule V
18‑18‑301
Rules
18‑18‑302
Registration requirements - definitions
18‑18‑303
Registration
18‑18‑304
Suspension or revocation of registration
18‑18‑305
Order to show cause
18‑18‑306
Records of registrants
18‑18‑307
Order forms
18‑18‑308
Prescriptions
18‑18‑309
Diversion prevention and control
18‑18‑401
Legislative declaration
18‑18‑402
Definitions - terms used
18‑18‑403
Additional definition
18‑18‑403.5
Unlawful possession of a controlled substance - notice to revisor of statutes - repeal
18‑18‑404
Unlawful use of a controlled substance
18‑18‑405
Unlawful distribution, manufacturing, dispensing, or sale
18‑18‑406
Offenses relating to marijuana and marijuana concentrate - definitions
18‑18‑406.1
Unlawful use or possession of synthetic cannabinoids or salvia divinorum
18‑18‑406.2
Unlawful distribution, manufacturing, dispensing, sale, or cultivation of synthetic cannabinoids or salvia divinorum
18‑18‑406.3
Medical use of marijuana by persons diagnosed with debilitating medical conditions - unlawful acts - penalty - medical marijuana program cash fund
18‑18‑406.4
Unlawful advertising of marijuana - exception
18‑18‑406.5
Unlawful use of marijuana in a detention facility
18‑18‑406.6
Extraction of marijuana concentrate - definitions
18‑18‑406.9
Unlawful distribution or purchase of dextromethorphan - penalty - preemption - definitions
18‑18‑407
Special offender - definitions
18‑18‑409
Reduction or suspension of sentence for providing substantial assistance
18‑18‑410
Declaration of class 1 public nuisance
18‑18‑411
Keeping, maintaining, controlling, renting, or making available property for unlawful distribution or manufacture of controlled substances
18‑18‑412
Abusing toxic vapors - prohibited
18‑18‑412.5
Unlawful possession of materials to make methamphetamine and amphetamine - penalty
18‑18‑412.7
Sale or distribution of materials to manufacture controlled substances
18‑18‑412.8
Retail sale of methamphetamine precursor drugs - unlawful acts - penalty
18‑18‑413
Authorized possession of controlled substances
18‑18‑414
Unlawful acts - licenses - penalties
18‑18‑415
Fraud and deceit
18‑18‑416
Controlled substances - inducing consumption by fraudulent means
18‑18‑417
Notice of conviction
18‑18‑418
Exemptions
18‑18‑419
Imitation and counterfeit controlled substances act
18‑18‑420
Imitation controlled substances - definitions
18‑18‑421
Imitation controlled substances - determination - considerations
18‑18‑422
Imitation controlled substances - violations - penalties
18‑18‑423
Counterfeit substances prohibited - penalty
18‑18‑424
Imitation controlled substances - exceptions
18‑18‑425
Drug paraphernalia - legislative declaration
18‑18‑426
Drug paraphernalia - definitions
18‑18‑427
Drug paraphernalia - determination - considerations
18‑18‑428
Possession of drug paraphernalia - penalty
18‑18‑429
Manufacture, sale, or delivery of drug paraphernalia - penalty
18‑18‑430
Advertisement of drug paraphernalia - penalty
18‑18‑430.5
Drug paraphernalia - exemption
18‑18‑431
Defenses
18‑18‑432
Drug offender public service and rehabilitation program - definitions
18‑18‑433
Constitutional provisions
18‑18‑434
Offenses relating to natural medicine and natural medicine product - definitions
18‑18‑501
Administrative inspections and warrants
18‑18‑502
Injunctions
18‑18‑503
Cooperative arrangements and confidentiality
18‑18‑504
Pleadings - presumptions - liabilities
18‑18‑505
Judicial review
18‑18‑506
Education and research
18‑18‑601
Pending proceedings - applicability
18‑18‑602
Continuation of rules - application to existing relationships
18‑18‑603
Statutes of limitations
18‑18‑604
Uniformity of interpretation
18‑18‑605
Severability
18‑18‑606
Drug case data collection
18‑18‑607
Safe stations - disposal of controlled substances - medical evaluation - definition
Green check means up to date. Up to date

Current through Fall 2024

§ 18-18-206’s source at colorado​.gov